Growth Metrics

Nexalin Technology (NXL) Cash & Equivalents (2022 - 2025)

Historic Cash & Equivalents for Nexalin Technology (NXL) over the last 4 years, with Q3 2025 value amounting to $3.8 million.

  • Nexalin Technology's Cash & Equivalents fell 1661.26% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year decrease of 1661.26%. This contributed to the annual value of $2.9 million for FY2024, which is 2268.53% up from last year.
  • As of Q3 2025, Nexalin Technology's Cash & Equivalents stood at $3.8 million, which was down 1661.26% from $5.4 million recorded in Q2 2025.
  • Nexalin Technology's Cash & Equivalents' 5-year high stood at $7.9 million during Q3 2022, with a 5-year trough of $848796.0 in Q2 2024.
  • Its 4-year average for Cash & Equivalents is $3.9 million, with a median of $3.8 million in 2025.
  • Per our database at Business Quant, Nexalin Technology's Cash & Equivalents crashed by 8098.97% in 2024 and then soared by 53165.53% in 2025.
  • Nexalin Technology's Cash & Equivalents (Quarter) stood at $6.8 million in 2022, then crashed by 65.33% to $2.4 million in 2023, then rose by 22.69% to $2.9 million in 2024, then rose by 29.5% to $3.8 million in 2025.
  • Its Cash & Equivalents stands at $3.8 million for Q3 2025, versus $5.4 million for Q2 2025 and $1.4 million for Q1 2025.